Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HBNB | FSV |
|---|---|---|
| Price | $4.51 | $126.87 |
| Change today | ▼ 2.39% | ▼ 1.51% |
| Market cap | $1.06B | $5.54B |
| Return, 3 months | -23.6% | -10.8% |
| Return, year to date | -39.6% | -17.9% |
| Return, 1 year | +41.4% | -30.8% |
| P/E (TTM) | -39.6 | 35.9 |
| P/B | 61.8 | 4.5 |
| P/E percentile vs own 5y | 21st | 1st |
| Dividend yield | – | 0.91% |
| Revenue growth (YoY, latest qtr) | +1,177.7% | +2.4% |
| Net profit growth (YoY) | -311.1% | +9.9% |
| Gross margin | 42.8% | 33.4% |
| Operating margin | 1.9% | 6.2% |
| Net margin | -35.2% | 2.9% |
| Return on equity | -288.3% | 13.1% |
| Analyst target vs. price | – | +38.1% |
| Analyst buy share | – | 83% |
| RSI (14) | 39 | 37 |
| 30-day volatility | 57.8% | 26.0% |
| Max drawdown, 1 year | -54.9% | -33.9% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
